Profile data is unavailable for this security.
About the company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
- Revenue in HKD (TTM)745.47m
- Net income in HKD113.40m
- Incorporated1996
- Employees948.00
- LocationShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdZhangjiang Hi-tech ParkNo.308 Cailun RoadPudong District, Zhangjiang Hi-tech ParkSHANGHAI 201210ChinaCHN
- Phone+86 2 158553583
- Fax+86 2 158553893
- Websitehttp://www.fd-zj.com
More ▼
6.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Hong Kong Ltd.as of 08 May 2024 | 16.16m | 4.96% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 3.75m | 1.15% |
| DFA Australia Ltd.as of 30 Sep 2024 | 15.32k | 0.01% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 0.00 | 0.00% |
| Asset Management One Co., Ltd.as of 24 Nov 2022 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
